| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 43.271 | 47.252 | 45.469 | 58.396 | 44.264 | 36.652 | 49.167 | 40.047 | 30.196 | 48.455 |
| Total Income - EUR | 43.272 | 47.274 | 45.774 | 58.396 | 44.265 | 36.652 | 50.609 | 41.967 | 32.804 | 48.673 |
| Total Expenses - EUR | 35.361 | 38.686 | 39.440 | 47.008 | 38.897 | 28.084 | 37.319 | 38.547 | 34.482 | 36.015 |
| Gross Profit/Loss - EUR | 7.910 | 8.589 | 6.334 | 11.388 | 5.368 | 8.568 | 13.290 | 3.420 | -1.678 | 12.658 |
| Net Profit/Loss - EUR | 6.296 | 8.116 | 5.515 | 10.825 | 4.902 | 8.223 | 12.794 | 3.063 | -1.970 | 11.227 |
| Employees | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Filden Group Medica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.355 | 3.384 | 3.646 | 5.345 | 5.642 | 4.453 | 3.297 | 5.301 | 4.374 | 3.444 |
| Current Assets | 6.064 | 5.929 | 4.078 | 6.842 | 3.656 | 11.614 | 12.174 | 9.074 | 1.958 | 9.436 |
| Inventories | 206 | 333 | 425 | 167 | 227 | 1.856 | 2.966 | 269 | 0 | 0 |
| Receivables | 34 | 206 | 33 | 3.157 | 634 | 6.825 | 5.830 | 4.405 | 437 | 2.358 |
| Cash | 5.825 | 5.390 | 3.620 | 3.519 | 2.795 | 2.933 | 3.377 | 4.400 | 1.521 | 7.078 |
| Shareholders Funds | 6.521 | 8.339 | 5.735 | 11.040 | 5.114 | 13.239 | 12.996 | 11.462 | 4.865 | 12.022 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 3.899 | 974 | 1.990 | 1.148 | 4.184 | 2.827 | 2.510 | 2.913 | 1.467 | 858 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Filden Group Medica Srl